UBS Group
EXAS

UBS Group’s Exact Sciences EXAS Stock Holding History

UBS Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-56,600
Closed -$5.75M – 10684
2025
Q4 		$5.75M Buy
+56,600
New +$4.55M ﹤0.01% 3889
2024
Q2 		– Sell
-26,100
Closed -$1.8M – 9673
2024
Q1 		$1.8M Buy
+26,100
New +$1.65M ﹤0.01% 4051
2022
Q1 		– Sell
-44,000
Closed -$3.42M – 10425
2021
Q4 		$3.42M Hold
44,000
– – ﹤0.01% 3240
2021
Q3 		$4.2M Sell
44,000
-30,000
-41% -$3.17M ﹤0.01% 2861
2021
Q2 		$9.2M Buy
74,000
+44,000
+147% +$5.25M ﹤0.01% 2119
2021
Q1 		$3.95M Sell
30,000
-10,000
-25% -$1.37M ﹤0.01% 2861
2020
Q4 		$5.3M Hold
40,000
– – ﹤0.01% 2386
2020
Q3 		$4.08M Hold
40,000
– – ﹤0.01% 2386
2020
Q2 		$3.48M Hold
40,000
– – ﹤0.01% 2366
2020
Q1 		$2.32M Buy
40,000
+5,000
+14% +$406K ﹤0.01% 2623
2019
Q4 		$3.24M Buy
+35,000
New +$3.08M ﹤0.01% 3051
2016
Q1 		– Sell
-200
Closed -$2K – 7782
2015
Q4 		$2K Hold
200
– – ﹤0.01% 8004
2015
Q3 		$4K Hold
200
– – ﹤0.01% 7807
2015
Q2 		$6K Hold
200
– – ﹤0.01% 7780
2015
Q1 		$4K Sell
200
-500
-71% -$12.7K ﹤0.01% 8212
2014
Q4 		$19K Buy
+700
New +$17K ﹤0.01% 7732

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

UBS Group's EXAS Position: Q1 2026 in Review

UBS Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,989,407 shares — an estimated $304M sold.

UBS Group first reported a position in EXAS in Q4 2014 and held it in 45 quarters. The position peaked at $304M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • UBS Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 2,989,407 Exact Sciences shares in Q1 2026, an estimated $304M.
  • UBS Group first reported a position in Exact Sciences in Q4 2014 and held it in 45 quarters.
  • UBS Group's Exact Sciences position peaked at $304M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.